The IP Fallout from Brexit: Assessing Consequences for New and Existing Patents

October 16, 2018 11:45am

Julia Florence
Assistant General Counsel (Patents)
GlaxoSmithKline

With less than one year to go until UK formally withdraws from the European Union, this session raises the important IP questions that will affect all life science companies and provides answers for how better to prepare for this imminent major change.
  • The Unitary Patent Court – how will this be affected after Britain leaves?
  • What are the consequences of Brexit on IP? How does it affect SPCs and the UPC?
  • Understanding whether SPCs granted under existing law can still be utilised after Brexit